IGI Logo

Bajaj Healthcare is currently trading at Rs. 431.15, up by 17.75 points or 4.29% from its previous closing of Rs. 413.40 on the BSE.

The scrip opened at Rs. 428.15 and has touched a high and low of Rs. 448.00 and Rs. 424.85 respectively. So far 56756 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 457.55 on 02-Jan-2023 and a 52 week low of Rs. 245.05 on 31-May-2023.

Last one week high and low of the scrip stood at Rs. 448.00 and Rs. 373.45 respectively. The current market cap of the company is Rs. 1140.92 crore.

The promoters holding in the company stood at 67.49%, while Institutions and Non-Institutions held 1.03% and 31.48% respectively.

Bajaj Healthcare has received Establishment Inspection Report (EIR) from the United State Food and Drug Administration (USFDA), for the Pre-approval inspection that was carried out by the USFDA in November, 2022 at its API manufacturing facility in Savli, Vadodara, Gujarat, with Zero 483 observations (No inspectional observations).

The receipt of the Establishment Inspection Report signifies the successful conclusion of the inspection. It serves as a testament to its dedication to upholding global standards of quality and compliance

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.